Walgreens pushes ahead on trial diversity
from The Refill, by MM+M Hosted by Heerea Rikhraj, Ramita Tandon, Jack O'Brien, Lecia Bushak, Marc Iskowitz
Walgreens’ Ramita Tandon, chief clinical trials officer, explains how the pharmacy chain is working with biopharma to enhance research inclusivity amid ongoing challenges to DEI on the federal and corporate level, in a conversation with MM+M’s Heerea Rikhraj. For our Trends segment, we’ll discuss what the end of the semaglutide shortage means for Hims and Hers and other telehealth firms that have been selling compounded versions of GLP-1 drugs, as well as how RFK Jr. is harnessing the CDC's comms apparatus to further his MAHA agenda. Music by Sixième Son Is your team still treating AI like a side experiment while competitors use it to win? Cut through the buzzword fatigue. On November 12th, join hundreds of top marketers in New York City for AI Deciphered, presented by Campaign, MM+M, and PRWeek. Get real-world playbooks from leaders like Reddit’s Rob Gaige and Yahoo’s Matt Sanchez across dedicated tracks built for daily execution. Check us out at: mmm-online.com Follow us: YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.
Embed this episode
What this episode covers
Walgreens’ Ramita Tandon explains how the pharmacy chain is working with biopharma to enhance inclusivity in clinical trials.
No transcript yet.